ARDT
Ardent Health Partners, Inc.
10.90$
+1.9%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -2.3% | +6.9% | +2.2% | -1.4% | +10.8% | -6.8% | +9.9% | -4.2% | +1.8% | -0.2% | +1.3% | – | |
| – | +0.4% | -56.9% | +0.6% | -2.9% | +159.7% | -60.4% | +4.6% | +150.1% | +37.2% | +46.0% | +12.5% | – | |
| – | -4.4% | +57.9% | +2.6% | -1.1% | -20.5% | +30.0% | +11.0% | -34.5% | -24.9% | -63.6% | -60.5% | – | |
| – | +7.6% | +257.6% | +1.0% | +1.6% | -70.6% | +250.8% | +3.0% | -70.5% | +23.3% | -15.7% | +24.4% | – | |
| – | +3.4% | +91.9% | +23.8% | -17.6% | -45.4% | +90.3% | +5.6% | -47.8% | -11.5% | -71.1% | -67.4% | – | |
| – | -23.7% | -55.9% | -307.6% | – | +378.5% | -80.1% | +104.6% | +85.3% | -58.8% | -22.8% | -46.6% | – | |
| – | -49.7% | +78.0% | +6.6% | -19.4% | -7.5% | +4.8% | +3.9% | -5.5% | -11.0% | -13.2% | +17.0% | – | |
| – | -80.8% | +540.8% | +45.3% | -30.6% | +193.1% | -55.6% | +64.4% | -101.8% | – | -19.2% | -42.1% | – | |
| – | -126.9% | – | +42.1% | -27.3% | +138.2% | -42.2% | +72.6% | -113.0% | – | -11.1% | -47.1% | – | |
| – | -119.9% | – | +58.1% | -38.5% | +333.9% | -63.8% | +76.3% | -132.2% | – | -11.4% | -57.6% | – | |
| – | -38.1% | +75.3% | +25.4% | -20.6% | +80.2% | -36.3% | +41.3% | -68.4% | +162.1% | -12.0% | -43.9% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.